• Explore /
  • Poster
  • / A phase II study of sorafenib and yttrium-90 glass microspheres for advanced hepatocellular carcinoma, BCLC stage C.

A phase II study of sorafenib and yttrium-90 glass microspheres for advanced hepatocellular carcinoma, BCLC stage C.

Abstract Poster

Authors

Ahmed Kaseb

Ahmed Omar Kaseb

GI Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX

Ahmed Omar Kaseb , Reham Abdel-Wahab , Ravi Murthy , Manal Hassan , Kanwal Pratap Singh Raghav , Lianchun Xiao , Jeffrey Morris , Rony Avritscher , Bruno C. Odisio , Chimela Ohaji , Robert A. Wolff , James C. Yao , Armeen Mahvash

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT01900002

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4083)

DOI

10.1200/JCO.2017.35.15_suppl.4083

Abstract #

4083

Poster Bd #

75

Abstract Disclosures

Similar Posters

First Author: Tim Meyer

First Author: Imane H. El Dika

First Author: Mingyue Cai

First Author: Jaekyung Cheon